Delivery Order SPE2DR25D3012-SPE2DR26F4L6M
- Not listed
- The Defense Logistics Agency issued a $2,220.42 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Zilretta 32 mg vials, with final delivery by May 13, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside and draws against the company's pharmaceutical supply vehicle with DLA Troop Support Medical. Amerisourcebergen operates as a pharmaceutical distributor and medical supplier serving Defense Health Agency and military treatment...
- The Defense Logistics Agency issued a $2,220.42 delivery order to Amerisourcebergen Drug Corp on April 8, 2026, for Zilretta 32 mg vials with an ultimate completion date of April 29, 2026. This is a firm fixed-price order issued under the DLA Troop Support Medical IDC (SPE2DX), a single-award indefinite delivery contract valued at $999,999,999.00 through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance...
- The Defense Logistics Agency awarded a $699.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 32 mg vials of Zilretta. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency requirements. Amerisourcebergen will perform under the delivery order from July 11, 2023 through August 1, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a $7,193.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of December 9, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA...
- The Defense Logistics Agency issued a $1,110.21 delivery order to Amerisourcebergen Drug Corp on March 27, 2026, for Zilretta 32 mg vials, with an ultimate completion date of April 17, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and was...
- The Defense Logistics Agency issued a $9,251.75 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Zilretta 32 mg vials, with an ultimate completion date of March 26, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling delivery of pharmaceutical products and medical supplies to military healthcare programs...
- <p>The Defense Logistics Agency issued a $7,401.40 delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for Zilretta 32 mg vials, with final completion by April 30, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued up to $999,999,999 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a $1,850.35 delivery order to AmerisourceBergen Drug Corp on March 12, 2026, for Zilretta 32 mg vials under its parent Indefinite Delivery Contract with the DLA Troop Support Medical.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is April 2, 2026. The order carries firm fixed pricing with no set-aside.</p>
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for the supply of Zilretta 32 mg vials, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively through the federal procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4L6MDelivery Order
The Defense Logistics Agency issued a $11,102.10 delivery order to Amerisourcebergen Drug Corp on April 30, 2026, for Zilretta 32 mg vials, with performance completed by May 21, 2026. Place of performance is Conshohocken, PA. The order was issued on a firm fixed-price basis with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to defense and federal healthcare systems. The company holds a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for military healthcare supply.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 4/29/26 |